» Articles » PMID: 38230256

Use of a Catch-up Programme to Improve Routine Immunization in 13 Provinces of Papua New Guinea, 2020-2022

Abstract

Objective: Routine immunization coverage in Papua New Guinea has decreased in the past 5 years. This persistently low routine immunization coverage has resulted in low population immunity and frequent outbreaks of vaccine-preventable disease across the country. We describe the use of a catch-up programme to improve routine immunization during the coronavirus disease pandemic in Papua New Guinea during 2020-2022.

Methods: In June 2020, 13 provinces of Papua New Guinea were selected to undergo a vaccination catch-up programme, with technical support from the World Health Organization (WHO) and the United Nations Children's Fund. Twelve provinces received financial and logistic support through the Accelerated Immunization and Health Systems Strengthening programme, and one received support from WHO. All stakeholders were involved in planning and implementing the catch-up programme.

Results: Between July 2020 and June 2022, about 340 health facilities conducted catch-up activities. The highest number of children aged under 1 year were vaccinated in 2022 ( = 33 652 for third dose of pentavalent vaccine). The national coverage of routine immunization (including the catch-up vaccinations) increased between 2019 and 2020 - by 5% for the third dose of pentavalent vaccine, 11% for the measles-rubella vaccine and 16% for the inactivated poliovirus vaccine. The coverage declined slightly in 2021 before increasing again in 2022.

Discussion: The catch-up programme was an instrumental tool to improve routine immunization coverage between 2020 and 2022 and during the pandemic in Papua New Guinea. With appropriate technical and logistic support, including financial and human resources, catch-up programmes can strengthen routine immunization coverage across the country.

Citing Articles

Continuous quality improvement in a community-wide TB screening and prevention programme in Papua New Guinea.

Pank N, Aung A, Kama G, Murray A, Huang K, Greig J Public Health Action. 2024; 14(3):97-104.

PMID: 39239158 PMC: 11373741. DOI: 10.5588/pha.24.0013.

References
1.
Bauri M, Wilkinson A, Ropa B, Feldon K, Snider C, Anand A . Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response - Papua New Guinea, 2018. MMWR Morb Mortal Wkly Rep. 2019; 68(5):119-120. PMC: 6366675. DOI: 10.15585/mmwr.mm6805a6. View

2.
Abbas K, Procter S, van Zandvoort K, Clark A, Funk S, Mengistu T . Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health. 2020; 8(10):e1264-e1272. PMC: 7367673. DOI: 10.1016/S2214-109X(20)30308-9. View

3.
Ichimura Y, Yamauchi M, Yoshida N, Miyano S, Komada K, Thandar M . Effectiveness of immunization activities on measles and rubella immunity among individuals in East Sepik, Papua New Guinea: A cross-sectional study. IJID Reg. 2022; 3:84-88. PMC: 9216679. DOI: 10.1016/j.ijregi.2022.03.001. View

4.
Gowin E, Kuzma J, Januszkiewicz-Lewandowska D . Knowledge among the rural parents about the vaccinations and vaccination coverage of children in the first year of life in Papua New Guinea - analysis of data provided by Christian health services. BMC Infect Dis. 2021; 21(1):130. PMC: 7847142. DOI: 10.1186/s12879-021-05824-2. View

5.
Ota M, Badur S, Romano-Mazzotti L, Friedland L . Impact of COVID-19 pandemic on routine immunization. Ann Med. 2021; 53(1):2286-2297. PMC: 8648038. DOI: 10.1080/07853890.2021.2009128. View